Noemi Cabrera, APRN

NPI: 1558872986
Total Payments
$7,497
2024 Payments
$476.18
Companies
32
Transactions
299
Medicare Patients
546
Medicare Billing
$39,513

Payment Breakdown by Category

Food & Beverage$7,209 (96.2%)
Education$288.31 (3.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,209 295 96.2%
Education $288.31 4 3.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,222 69 $0 (2024)
Novo Nordisk Inc $896.32 46 $0 (2024)
Astellas Pharma US Inc $699.27 36 $0 (2024)
AstraZeneca Pharmaceuticals LP $693.21 28 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $583.06 19 $0 (2023)
NESTLE HEALTHCARE NUTRITION INC. $390.65 9 $0 (2023)
Lilly USA, LLC $301.01 24 $0 (2024)
Hologic Sales and Service, LLC $296.95 2 $0 (2023)
Ironwood Pharmaceuticals, Inc $251.95 11 $0 (2023)
Merck Sharp & Dohme LLC $250.40 13 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $476.18 16 ABBVIE INC. ($318.23)
2023 $2,466 110 ABBVIE INC. ($557.89)
2022 $3,361 118 ABBVIE INC. ($968.10)
2021 $1,194 55 Novo Nordisk Inc ($379.58)

All Payment Transactions

299 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
10/23/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $27.94 General
Category: GASTROENTEROLOGY
09/04/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $12.45 General
Category: GASTROENTEROLOGY
08/28/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $21.31 General
Category: Biological
07/31/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $25.58 General
Category: GASTROENTEROLOGY
05/08/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $31.16 General
Category: GASTROENTEROLOGY
05/07/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $22.85 General
Category: GASTROENTEROLOGY
05/02/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.67 General
Category: Diabetes
04/25/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $123.55 General
Category: ENDOCRINOLOGY
04/22/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $29.29 General
Category: Inflammation
04/18/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $21.16 General
Category: GASTROENTEROLOGY
03/27/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $27.84 General
Category: Diabetes Care
02/28/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.23 General
Category: NEUROSCIENCE
02/23/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $16.99 General
Category: Diabetes Care
02/20/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $23.43 General
Category: Biological
02/06/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $17.42 General
Category: Diabetes
01/17/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $29.31 General
Category: GASTROENTEROLOGY
12/21/2023 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $20.50 General
12/19/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $34.87 General
Category: IMMUNOLOGY
12/15/2023 Ironwood Pharmaceuticals, Inc Linzess (Drug) Food and Beverage Cash or cash equivalent $13.84 General
Category: GI
12/11/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $5.08 General
Category: Diabetes
12/08/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $9.19 General
Category: IMMUNOLOGY
12/07/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.57 General
Category: Cardiovascular and Metabolism
12/06/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.48 General
Category: Inflammation
12/06/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.78 General
Category: Gastroenterology
12/05/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $18.55 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 150 215 $32,635 $11,082
2022 6 232 384 $39,105 $16,621
2021 4 152 208 $21,305 $10,898
2020 1 12 22 $3,432 $912.24
Total Patients
546
Total Services
829
Medicare Billing
$39,513
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 75 130 $18,800 $5,808 30.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 32 $7,540 $2,592 34.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 18 18 $5,280 $1,957 37.1%
99497 Advance care planning, first 30 minutes Office 2023 16 16 $730.00 $663.41 90.9%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2023 14 19 $285.00 $60.99 21.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 127 265 $29,150 $12,604 43.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 30 30 $7,200 $3,395 47.2%
G0444 Annual depression screening, 15 minutes Office 2022 20 20 $600.00 $318.76 53.1%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2022 26 40 $600.00 $129.18 21.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 16 16 $1,360 $129.01 9.5%
81002 Urinalysis, manual test Office 2022 13 13 $195.00 $44.59 22.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 75 121 $13,310 $7,093 53.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 28 28 $6,720 $3,271 48.7%
G0444 Annual depression screening, 15 minutes Office 2021 26 26 $780.00 $425.62 54.6%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2021 23 33 $495.00 $108.24 21.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 12 22 $3,432 $912.24 26.6%

About Noemi Cabrera, APRN

Noemi Cabrera, APRN is a Family healthcare provider based in North Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1558872986.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Noemi Cabrera, APRN has received a total of $7,497 in payments from pharmaceutical and medical device companies, with $476.18 received in 2024. These payments were reported across 299 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,209).

As a Medicare-enrolled provider, Cabrera has provided services to 546 Medicare beneficiaries, totaling 829 services with total Medicare billing of $39,513. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location North Las Vegas, NV
  • Active Since 10/12/2017
  • Last Updated 05/02/2025
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1558872986

Products in Payments

  • UBRELVY (Drug) $645.61
  • FARXIGA (Drug) $566.70
  • CREON (Drug) $528.85
  • JARDIANCE (Drug) $499.39
  • QULIPTA (Drug) $402.91
  • LINZESS (Drug) $391.93
  • ZENPEP (Drug) $390.65
  • Ozempic (Drug) $353.74
  • APTIMA (Device) $296.95
  • Rybelsus (Drug) $294.99
  • Linzess (Drug) $251.95
  • Myrbetriq (Drug) $224.75
  • MOUNJARO (Drug) $218.15
  • RYBELSUS (Drug) $159.40
  • Veozah (Drug) $145.76
  • BELSOMRA (Drug) $138.98
  • XIFAXAN (Drug) $134.37
  • Otezla (Drug) $108.80
  • FREESTYLE LIBRE 3 (Device) $86.93
  • NEXLIZET (Drug) $78.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in North Las Vegas